The TREAT Trial was presented at the ASN in San Diego. This much publicized trial examined the role of Aranesp in the management of diabetic patients with CKD. One group was randomized to receive Aranesp with a hemoglobin target of 130 g/l while the ...
No Statistically Significant Difference in Cardiovascular and Renal Composite Endpoints Between Aranesp and Placebo THOUSAND OAKS, Calif., Aug. 25 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN) today announced that in a large, ra...
The KDIGO guideline group has released its bone and mineral guidelines. These can be seen online at this link. Alternatively, you may download the .PDF of these guidelines using this link Dr. Jeff Berns, editor in chief of Medscape Nephrology,...
In the latest edition of the Journal American Association of Nephrology, investigators report that sodium bicarbonate administration delays the progression of kidney disease to end-stage renal failure. 134 adult patients with CKD (creatinine clearanc...
KIRKLAND, QC, June 3 /CNW/ - A new treatment option for heart failure is now available in Canada (from CNW Group) Canada as an adjunct to standard therapy, to reduce the risk of deathfollowing a heart attack in clinically stable patients who have e...
